-

Dexlevo’s GOURI Symposium and Brand Event at IMCAS 2023

SEOUL, South Korea--(BUSINESS WIRE)--Dexlevo, a company specializing in aesthetic medical devices, successfully held a symposium dedicated to its exclusive product, ‘GOURI’, at the IMCAS World Congress 2023 in Paris. IMCAS (International Master Course on Aging Science), held from Jan 26th to Jan 28th in Paris, France, is one of the world's three major aesthetics anti-aging societies.

Over 200 doctors and companies who visited Dexlevo's booth showed great interest in GOURI – a unique injectable that provides a fundamental solution to anti-aging.

GOURI symposium titled “Universal Anti-Aging Treatment” was conducted by an Australian dermatologist Dr. Paul Han, who apart from giving a lecture also demonstrated a new GOURI treatment protocol which lately has gained increasing popularity among doctors who use GOURI. Dr. Paul commented, “While keeping the results as great as we had with the previous protocol, the new one dramatically improves the patient’s experience and reduces the patient’s fear of treatment due to pain.”

An exclusive Dexlevo’s brand event called Gorgeous GOURI Night was held on the evening of Jan 26th. It was a customized event where GOURI doctors and distributors worldwide could share their experience and knowledge about the product. After the “Gorgeous GOURI Experience” session, where doctors freely presented their cases and treatment experiences, guests got a chance to experience Korean traditional music – gugak – and clothing – hanbok.

Dexlevo’s representative said, “Through Gorgeous GOURI Night, an exclusive event dedicated solely to GOURI, we aimed to enhance product understanding and promote brand awareness. It was an opportunity for doctors to expand their network” and added, “We plan to keep demonstrating the excellence of GOURI through various marketing activities, such as holding brand events and participating in international anti-aging conferences.”

Dexlevo’s GOURI is the world's first liquefied polycaprolatone (PCL) collagen stimulator that naturally spreads throughout the face after injection, including the area around the eyes, to induce collagen production.

Contacts

DEXLEVO
Lia Ko
lia.Ko@dexlevo.com
+821051022559

More News From DEXLEVO

DEXLEVO at AMWC JAPAN: a Successful Debut

SEOUL, South Korea--(BUSINESS WIRE)--DEXLEVO, a company specializing in beauty medical devices, attended the Aesthetic and Anti-Aging Medicine World Congress (AMWC Japan) held for the first time in Japan. AMWC is one of the world’s three major beauty anti-aging conferences. AMWC congress was launched this year in Japan to activate the East Asian market with Japan as an aesthetic medicine and anti-aging hub. DEXLEVO participated as a sponsor and exhibitor at AMWC Japan, which was held in Tokyo o...

DEXLEVO Strengthens Global Reputation of GOURI at IMCAS, the World’s Largest Beauty Anti-Aging Society

SEOUL, South Korea--(BUSINESS WIRE)--DEXLEVO, an aesthetic medical device company, attended the international conference on cosmetic formation opening in Paris, IMCAS World Congress 2022 on 2022.06.03~06.05, and introduced the excellence and effectiveness of ‘GOURI’. IMCAS World Congress is one of the world’s top 3 cosmetic conferences, is an event where over 20,000 visitors from more than 195 countries, including dermatologists, participate every year to share the latest knowledge of the indus...

GS Global expands its portfolio with DEXLEVO for the EU and North America market

SEOUL, South Korea--(BUSINESS WIRE)--GS, which has announced its expansion into the bio business by acquiring Hugel, a botulinum toxin manufacturer, now seeks further business expansion. The group plans to diversify its business portfolio by collaborating with technology-competitive bio ventures. Recently, it is seen to consider synergy by combining botulinum toxin and fillers. According to industry sources, GS’s trading arm GS Global is exploring the global filler market by signing a strategic...
Back to Newsroom